Update in Inflammatory Bowel Disease
||Friday, November 19, 2010
|Marriott Inner Harbor Hotel
110 S. Eutaw Street, Baltimore, Maryland
Update in Inflammatory Bowel Disease is the 6th University of Maryland School of Medicine Division of Gastroenterology Symposium. This in-depth symposium will focus on treating patients with IBD and is intended for practicing physicians, surgeons, mid level providers, nurses, and nutritionists. The presentations, discussion periods and interactive formats are intended to stimulate audience participation in the discussion of these timely topics.
Inflammatory bowel disease (IBD), comprised of ulcerative colitis and Crohn's disease, affects approximately 1.4 million patients in the United States. Both diseases are chronic, characterized by periodic exacerbations of symptoms, and have a negative impact on quality of life. IBD affects women equally, (usually during childbearing age), and 15% of IBD patients are diagnosed in childhood. As such, IBD providers are often challenged to care for uniquely complex patients at important transition points in their lives. This care is administered in the face of continually evolving and controversial prognostic, diagnostic and therapeutic issues as the field of IBD advances. Given that over 50% of IBD patients report utilizing Complementary/Alternative Medicine therapies during their disease course, IBD providers must also be familiar with these 'nontraditional' but common interventions. Furthermore, as a significant proportion of patients will become refractory to therapy at some point in their disease, IBD providers must be able to recognize the complex reasons for treatment refractory disease and be prepared to appropriately escalate medical and surgical care when needed. Together, this makes it challenging for providers to ensure that IBD treatment is consistent with current guidelines and accepted standards. Since IBD is common and there is confusion regarding the optimal use of diagnostic tests, traditional and non-traditional therapeutics, and surgery in patients who are at important transition points in their lives, this one day symposium highlights the diagnosis and management of patients with these disorders.
Upon completion of this activity, participants should be able to:
- Understand how to treat patients with mild to moderate Crohn's disease and ulcerative colitis.
- Understand how to treat patients with severe Crohn's disease or ulcerative colitis, including use of biologic, endoscopic and surgical treatments.
- Understand unique aspects of treatment in women and children with inflammatory bowel disease.
- Understand evidence base for and appropriate use of complementary and alternative medicine in inflammatory bowel disease.
For More Information
To learn more, see the symposium brochure or symposium presentations.
For more information about our services or treatment options or to refer a patient to the IBD Program, please call 410-706-3387.